Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROSPER pilot trial in acute ischaemic stroke thrombectomy anaesthesia
ACTRN12621000074897Phase 4Completed
- Sponsor
- Metro South Health
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sevoflurane and propofol in brain infarction (2 arms), sponsored by Metro South Health. Primary endpoints: Recruitment feasibility, Protocol adherence feasibility and 1 more. Started Jun 2021; status: completed.
02
Drugs
sevofluranepropofol
03
Conditions
brain infarction
Beyond the preview
Go deeper on ACTRN12621000074897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000074897.